scispace - formally typeset
I

Ildar Gainetdinov

Researcher at University of Massachusetts Medical School

Publications -  33
Citations -  1586

Ildar Gainetdinov is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Piwi-interacting RNA & Argonaute. The author has an hindex of 13, co-authored 27 publications receiving 872 citations. Previous affiliations of Ildar Gainetdinov include Howard Hughes Medical Institute & Russian Academy of Sciences.

Papers
More filters
Journal ArticleDOI

PIWI-interacting RNAs: small RNAs with big functions

TL;DR: The authors describe the latest understanding of piRNA biogenesis and functions across diverse species, highlighting how, despite the universal importance of transposon control, different species have evolved intriguingly distinct mechanistic routes to achieve this.
Journal ArticleDOI

A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing

TL;DR: Nme2Cas9 combines all-in-one AAV compatibility, exceptional editing accuracy within cells, and high target site density for in-vivo genome editing applications and expands the single-AAV platform to pre-implanted zygotes for streamlined generation of genome-edited mice.
Journal ArticleDOI

A Single Mechanism of Biogenesis, Initiated and Directed by PIWI Proteins, Explains piRNA Production in Most Animals.

TL;DR: The unified model places PIWI-clade Argonautes at the center of piRNA biology and suggests that the ancestral animal-the Urmetazoan-used PIWI proteins both to generate piRNA guides and to execute piRNA function.
Journal ArticleDOI

The evolutionarily conserved piRNA-producing locus pi6 is required for male mouse fertility

TL;DR: It is reported that males lacking piRNAs from a conserved mouse pachytene piRNA locus on chromosome 6 (pi6) produce sperm with defects in capacitation and egg fertilization, and heterozygous embryos sired by pi6−/− fathers show reduced viability in utero.
Journal ArticleDOI

Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.

TL;DR: Two new type II-C anti-CRISPRs and their cognate Cas9 orthologs are identified and their functionality in vitro and in bacteria are validated, their inhibitory spectrum is defined, and their utility as off-switches for Cas9-based tools in mammalian applications is documented.